COMMUNIQUÉS West-GlobeNewswire

EssilorLuxottica: Le Conseil d’administration d’EssilorLuxottica propose des candidats pour le nouveau conseil
14/02/2024
Le Conseil d’administration d’EssilorLuxottica propose des candidats pour le nouveau conseil Charenton-le-Pont, France (14 février 2024 – 18h00) – Réuni aujourd'hui, le Conseil d’administration d'EssilorLuxottica a [...]
Hyloris Enrolls First Patient in Phase 3 Clinical Trial for its Proprietary Mouth Rinse to Control Incidences of Bleeding Related to Dental Procedures
14/02/2024
Innovative oral care solution aims to benefit patients taking blood thinning medications, who have an increased risk of prolonged bleeding during and after dental procedures Approximately 280 patients in the EU and U.S [...]
Hyloris Recrute un Premier Patient dans le Cadre d'un Essai Clinique de Phase 3 portant sur son Rince-Bouche Breveté Destiné à Contrôler les Saignements lors des Interventions Dentaires
14/02/2024
Une solution innovante de soins bucco-dentaires destinée aux patients prenant des médicaments anticoagulants, qui présentent un risque accru de saignement prolongé au cours et à la suite d'interventions dentaires [...]
ACTG Announces Launch of Clinical Trial Evaluating Drug-Drug Interaction in Shortened Tuberculosis Regimen Among People Living with HIV
14/02/2024
LOS ANGELES, Feb. 14, 2024 (GLOBE NEWSWIRE) -- ACTG, a global clinical trials network focused on HIV and other infectious diseases, today announced the opening of study A5406 ( Pharmacokinetics and Safety of Double-dose [...]
Genmab Announces Initiation of Share Buy-Back Program
14/02/2024
Company Announcement Repurchase of up to 190,000 shares Honoring commitments under our Restricted Stock Unit program Completion expected on March 15, 2024 COPENHAGEN, Denmark; February 14, 2024 – Genmab A/S (Nasdaq: [...]
Genmab Publishes 2023 Annual Report
14/02/2024
Company Announcement COPENHAGEN, Denmark; February 14, 2024 – Genmab A/S (Nasdaq: GMAB) announced today the publication of its Annual Report for 2023. Below is a summary of business progress in 2023, financial [...]
Alarming Study Reveals Safety Limits are Exceeded for Mercury Exposure from Dental Amalgams in Pregnant Women in the U.S.
14/02/2024
CHAMPIONSGATE, Fla., Feb. 14, 2024 (GLOBE NEWSWIRE) -- The International Academy of Oral Medicine and Toxicology (IAOMT) urgently highlights a concerning study, titled " Estimated mercury vapor exposure from amalgams [...]
Unity Care Awarded Grant Under "Outdoors for All" Initiative by California Natural Resources Agency and Governor Newsom
14/02/2024
SAN JOSE, Calif., Feb. 14, 2024 (GLOBE NEWSWIRE) -- Unity Care, a nonprofit organization that serves transition-age foster youth, has been selected to receive a grant under the “Outdoors for All” program, an initiative [...]
Statement of Renovaro Inc
14/02/2024
LOS ANGELES, Feb. 14, 2024 (GLOBE NEWSWIRE) -- The following is a statement by Renovaro (Nasdaq: RENB) in response to Hindenburg's recent opinion piece: We felt compelled to comment on the shorter Hindenburg’s opinion [...]
FOXO Technologies Announces Non-Binding Agreement for Potentially Transformative Merger with M2i Global
14/02/2024
Proposed Combination to Focus on Securing Our Nation’s Supply to Critical Materials and Resources MINNEAPOLIS, MN, Feb. 14, 2024 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (the “Company”), today [...]
Yield10 Bioscience Grants Global License to VISION Bioenergy Oilseeds for Herbicide Tolerant Camelina Cultivated for the Production of Biofuel Feedstock
14/02/2024
Global License of Industry-Leading Elite Herbicide Tolerant Camelina Accelerates Biofuel Feedstock Production WOBURN, Mass. and LONGMONT, Colo., Feb. 14, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN [...]
Nacuity Pharmaceuticals Announces Expansion of its Business Advisory Board with Appointment of Rare Disease Advocate Daniel Feller
14/02/2024
FORT WORTH, Texas, Feb. 14, 2024 (GLOBE NEWSWIRE) -- Nacuity Pharmaceuticals, Inc., a clinical stage biopharmaceutical company developing treatments for retinitis pigmentosa, cataracts and other ocular diseases caused [...]
SweetWater 420 Fest Announces 2024 Lineup With Headliners Beck and Slightly Stoopid
14/02/2024
Two-Day Festival Will Feature Performances from 25 Musicians, April 20 & 21, at Atlanta’s Historic Pullman Yards ATLANTA, Feb. 14, 2024 (GLOBE NEWSWIRE) -- SweetWater Brewing Company (“SweetWater Brewing” or “ [...]
Bicycle Health’s Second Opioid Use Disorder Index Reveals Persistent Gaps in Treatment
14/02/2024
New population-level data shows that people with opioid use disorder (OUD) struggle to access treatment, even following the elimination of the X-waiver. While 78% of people looking for virtual OUD treatment have [...]
AIM ImmunoTech Announces First Subject Dosed in the Netherlands for Phase 1b/2 Study Evaluating Ampligen® (rintatolimod) in Combination with AstraZeneca’s Imfinzi (durvalumab) for the Treatment of Pancreatic Cancer
14/02/2024
Phase 1b portion of the study expected to be completed within six months OCALA, Fla., Feb. 14, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced the first subject [...]
ZKR Orthopedics Receives IDE Approval for Clinical Trial
14/02/2024
SAN FRANCISCO, Feb. 14, 2024 (GLOBE NEWSWIRE) -- ZKR Orthopedics, Inc., a clinical stage medical device company, announced that it has received Investigational Device Exemption (IDE) approval from the United States Food [...]
SFWJ DBA MedCana Announces a Major Multiyear Contract between Eko2o S.A.S., a Majority-Controlled Subsidiary of MedCana and Danziger Colombia
14/02/2024
AUSTIN, Texas, Feb. 14, 2024 (GLOBE NEWSWIRE) -- – via IBN – SFWJ DBA MedCana announces that Eko2o S.A.S, a Majority Controlled subsidiary of MedCana/SWJ in Colombia and a leading provider of greenhouse infrastructure [...]
Safety Shot Brand Ambassador & Multiplatform Entertainer Matthew Espinosa to Share His Enthusiasm for the Wellness Beverage with 16 Million Followers
14/02/2024
JUPITER, FL, Feb. 14, 2024 (GLOBE NEWSWIRE) -- Safety Shot, Inc. (Nasdaq: SHOT) today announced that Matthew Espinosa joins Safety Shot as a brand ambassador to share his love and enthusiasm for the first patented [...]
Ashvattha Therapeutics to Participate in Upcoming Investor Conferences
14/02/2024
REDWOOD CITY, Calif., Feb. 14, 2024 (GLOBE NEWSWIRE) -- Ashvattha Therapeutics (“Ashvattha”), a clinical-stage company advancing a new class of nanomedicine therapeutics that traverse tissue barriers to selectively [...]

Pages